KLDO   $0.0001  0.0 Market Closed

Kaleido Biosciences Inc
Total Cash 38.47M
totalCashPerShare 0.903
EBITDA -85.16M
Total Debt 21.69M
quickRatio 1.328
currentRatio 1.425
Total Revenue 1.10M
debtToEquity 204.525
Revenue/Share 0.026
ROA -0.99928004
ROE -5.80574
grossProfits
freeCashflow -46.02M
operatingCashflow -77.09M
earningsGrowth
revenueGrowth 1.025
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -39.7439
profitMargins 0.0
enterpriseValue -16.78M
forwardPE
floatShares 42.45M
sharesOutstanding 42.62M
sharesShort 2.34M
sharesShortPriorMonth 2.16M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.0
heldPercentInstitutions 0.00%
Short Ratio help_outline 29.34%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue 0.249
Price To Book help_outline 0.00
earningsQuarterlyGrowth
netIncomeToCommon -90.29M
trailingEps -2.16%
forwardEps -0.85%
enterpriseToEbitda 0.20
lastDividendValue
lastDividendDate
currentQuarterEstimate 1Q 2022
institutionsCount 2
lastUpdated Nov. 7, 2024, 3:08 p.m.